We use cookies for a better user experience. Read our Privacy Policy
I Agree
Central Lab Market
Analysts’ Viewpoint on Central Lab Market Scenario
Companies in the central lab market are increasing efforts to implement home visit testing for several COVID-19 research studies and provide high quality support to logistics courier partners. Investigator site portals are providing intuitive and interactive tools for central lab sites in order to manage registered samples, subject enrollment, order collection kits, and the likes. Electronic lab requisition reduces the risk of sample loss by enabling a chain of custody before the sample leaves the clinic. However, study teams face complexities such as working with niche laboratories to evaluate decentralized clinical trial designs. Thus, to overcome these challenges, companies should transition toward AI, Blockchain, and automation technologies in laboratory trials management systems and for sample tracking.
Efficient service and quality data without compromise have become important focus points for companies in the central lab market. Companies are increasing efforts to streamline auditing, deviation management, and standard operating procedures.
Stakeholders in the market are committing to operational excellence in order to comply with the global standards as suggested by the College of American Pathologists (CAP), the Clinical Laboratory Improvement Amendments (CLIA), and the likes. As such, real-time central lab database management platforms are becoming a recurring market trend, since it can be automatically integrated with the patient or medical data of a clinical trial management system.
Request a sample to get extensive insights into the Central Lab Market
Companies in the central lab market have been under scrutiny for minimizing potential disruptions to the logistical movements of human samples and potential supply issues for clinical kits during the ongoing COVID-19 pandemic. Stakeholders of central laboratory support services are increasing efforts to closely work with its logistics providers and courier partners to implement alternative transportation solutions, owing to increased cost of transporting supplies.
Stakeholders in the market are collaborating with network laboratories to assess the current coronavirus situation and plan its potential impact on lab testing services. Laboratory vendors are closely monitoring and updating their business continuity plans in severely affected COVID-19 regions such as the U.K. and China. Stakeholders are working closely with their staff to monitor subject compliance.
To understand how our report can bring difference to your business strategy, Ask for a brochure
The central lab market is predicted to witness high revenue growth throughout the assessment tenure. However, central lab stakeholders are posed with many challenges such as time consuming processes, as several sites samples need to reach one lab and may take several days. Hence, central labs are now sharing this responsibility with local lab facilities, whilst increasing R&D to adopt processes that accelerate their lab procedures.
On the other hand, the German healthcare system in the central lab market poses issue in invoicing medical services to non-physician medical specialists in hospitals due to the scarcity of medical professionals. Hence, the German Society for Laboratory Medicine (DGKL) is increasing efforts to provide additional training in a master program in laboratory medicine aimed at medical professionals to facilitate invoicing for lab services in hospitals.
Stuck in a neck-to-neck competition with other brands? Request a custom report on Central Lab Market
The central lab market is slated to register a favorable CAGR during the forecast period. Companies are making use of its real-time laboratory information data portals for investigator sites and sponsors to have access to the data for their user accounts. Lab professionals are increasing efforts to provide 24/7 secured access to clinical trial information and authorized data reports. Companies are collaborating with software developers to secure laboratory information data portals with encrypted connections.
A plethora of technological and software innovations is storming the global central lab market. Clinical trial laboratory service organizations are supporting central labs with innovations such as artificial intelligence (AI) protocol reading, sample & consent tracking, and next-gen flow cytometry result reporting automation, among others.
Direct to patient kit shipments, blockchain for sample tracking, and electronic histology & pathology reports are benefitting stakeholders in the central lab market. They are unlocking growth opportunities for supporting decentralized virtual trials innovation. In order to achieve this, companies are partnering with mobile nurse and phlebotomy companies to enable in-home specimen collection from individuals and patients alike.
|
Attribute |
Detail |
|
Market Size Value in 2020 |
US$ 2.3 Bn |
|
Market Forecast Value in 2031 |
US$ 4 Bn |
|
Growth Rate (CAGR) |
5.4% |
|
Forecast Period |
2021–2031 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
Central Lab Market – Segmentation
TMR’s study on the global central lab market includes information divided into three segments: product, end-user, and region. Changing industry trends and other market dynamics associated with these segments of the global central lab market are discussed in detail.
| Product |
|
| End-user |
|
| Region |
|
Interested in this report?
Get a FREE Brochure now!
*Get Brochure Report (PDF) sent to your email within minutes
Central lab market is expected to reach the value of US$ 4 Bn by the end of 2031
Central lab market is estimated to expand at a CAGR of 5.4% from 2021 to 2031
Central lab market is driven by rise in demand for biomarkers in diagnostic therapeutic across the globe
North America accounted for a major share of the global central lab market
Key players operating in the global central lab market include ACM Global Central Lab, Barc Lab (Cerba Research), Bioscientia (Sonic Healthcare), Celerion, CIRION BioPharma Research
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Central Lab Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Central Lab Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
5.2. Strategies Adopted by Top 3 Players
5.3. Impact of Cell and Gene Therapy on Central Lab Market
5.4. Impact of Clinical Trial on Central Lab Market
5.5. Central Lab Market: SWOT Analysis
6. Global Central Lab Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Genetic Services
6.3.2. Biomarker Services
6.3.3. Microbiology Services
6.3.4. Anatomic Pathology/Histology
6.3.5. Specimen Management & Storage
6.3.6. Special Chemistry Services
6.3.7. Clinical Research & Trial Services
6.3.8. Others
6.4. Market Attractiveness Analysis, by Product
7. Global Central Lab Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017–2031
7.3.1. Pharmaceutical Companies
7.3.2. Biotechnology Companies
7.3.3. Academic and Research Institutes
7.4. Market Attractiveness Analysis, by End-user
8. Global Central Lab Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East and Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Central Lab Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2017–2031
9.2.1. Genetic Services
9.2.2. Biomarker Services
9.2.3. Microbiology Services
9.2.4. Anatomic Pathology/Histology
9.2.5. Specimen Management & Storage
9.2.6. Special Chemistry Services
9.2.7. Clinical Research & Trial Services
9.2.8. Others
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Pharmaceutical Companies
9.3.2. Biotechnology Companies
9.3.3. Academic and Research Institutes
9.4. Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country
10. Europe Central Lab Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2031
10.2.1. Genetic Services
10.2.2. Biomarker Services
10.2.3. Microbiology Services
10.2.4. Anatomic Pathology/Histology
10.2.5. Specimen Management & Storage
10.2.6. Special Chemistry Services
10.2.7. Clinical Research & Trial Services
10.2.8. Others
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Pharmaceutical Companies
10.3.2. Biotechnology Companies
10.3.3. Academic and Research Institutes
10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Central Lab Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Genetic Services
11.2.2. Biomarker Services
11.2.3. Microbiology Services
11.2.4. Anatomic Pathology/Histology
11.2.5. Specimen Management & Storage
11.2.6. Special Chemistry Services
11.2.7. Clinical Research & Trial Services
11.2.8. Others
11.3. Market Value Forecast, by End-user, 2017–2031
11.3.1. Pharmaceutical Companies
11.3.2. Biotechnology Companies
11.3.3. Academic and Research Institutes
11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Central Lab Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Genetic Services
12.2.2. Biomarker Services
12.2.3. Microbiology Services
12.2.4. Anatomic Pathology/Histology
12.2.5. Specimen Management & Storage
12.2.6. Special Chemistry Services
12.2.7. Clinical Research & Trial Services
12.2.8. Others
12.3. Market Value Forecast, by End-user, 2017–2031
12.3.1. Pharmaceutical Companies
12.3.2. Biotechnology Companies
12.3.3. Academic and Research Institutes
12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East and Africa Central Lab Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Genetic Services
13.2.2. Biomarker Services
13.2.3. Microbiology Services
13.2.4. Anatomic Pathology/Histology
13.2.5. Specimen Management & Storage
13.2.6. Special Chemistry Services
13.2.7. Clinical Research & Trial Services
13.2.8. Others
13.3. Market Value Forecast, by End-user, 2017–2031
13.3.1. Pharmaceutical Companies
13.3.2. Biotechnology Companies
13.3.3. Academic and Research Institutes
13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East and Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2020
14.3. Company Profiles
14.3.1. ACM Global Central Lab
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Company Financials
14.3.1.3. Growth Strategies
14.3.1.4. SWOT Analysis
14.3.2. Barc Lab (Cerba Research)
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Company Financials
14.3.2.3. Growth Strategies
14.3.2.4. SWOT Analysis
14.3.3. Bioscientia (Sonic Healthcare)
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Company Financials
14.3.3.3. Growth Strategies
14.3.3.4. SWOT Analysis
14.3.4. Celerion
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Company Financials
14.3.4.3. Growth Strategies
14.3.4.4. SWOT Analysis
14.3.5. CIRION BioPharma Research
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Company Financials
14.3.5.3. Growth Strategies
14.3.5.4. SWOT Analysis
14.3.6. Clinical Reference Laboratory
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Company Financials
14.3.6.3. Growth Strategies
14.3.6.4. SWOT Analysis
14.3.7. Eurofins Central Laboratory
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Company Financials
14.3.7.3. Growth Strategies
14.3.7.4. SWOT Analysis
14.3.8. Frontage Laboratories, Inc.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Company Financials
14.3.8.3. Growth Strategies
14.3.8.4. SWOT Analysis
14.3.9. ICON Central Labs.
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Company Financials
14.3.9.3. Growth Strategies
14.3.9.4. SWOT Analysis
14.3.10. INTERLAB Central Lab Services.
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Company Financials
14.3.10.3. Growth Strategies
14.3.10.4. SWOT Analysis
14.3.11. InVitro International
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Company Financials
14.3.11.3. Growth Strategies
14.3.11.4. SWOT Analysis
14.3.12. Lab Corp/Covance
14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.12.2. Company Financials
14.3.12.3. Growth Strategies
14.3.12.4. SWOT Analysis
14.3.13. LabConnect
14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.13.2. Company Financials
14.3.13.3. Growth Strategies
14.3.13.4. SWOT Analysis
14.3.14. Medpace
14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.14.2. Company Financials
14.3.14.3. Growth Strategies
14.3.14.4. SWOT Analysis
14.3.15. MLM Medical Labs GmbH.
14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.15.2. Company Financials
14.3.15.3. Growth Strategies
14.3.15.4. SWOT Analysis
14.3.16. PPD
14.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.16.2. Company Financials
14.3.16.3. Growth Strategies
14.3.16.4. SWOT Analysis
14.3.17. Q² Solutions
14.3.17.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.17.2. Company Financials
14.3.17.3. Growth Strategies
14.3.17.4. SWOT Analysis
14.3.18. Synevo Central Lab
14.3.18.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.18.2. Company Financials
14.3.18.3. Growth Strategies
14.3.18.4. SWOT Analysis
14.3.19. Other Prominent Players
14.3.19.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.19.2. Company Financials
14.3.19.3. Growth Strategies
14.3.19.4. SWOT Analysis
List of Tables
Table 01: Global Central Lab Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 02: Global Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 03: Global Central Lab Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 04: North America Central Lab Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 05: North America Central Lab Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 06: North America Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 07: Europe Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 08: Europe Central Lab Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 09: Europe Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 10: Asia Pacific Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 11: Asia Pacific Central Lab Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 12: Asia Pacific Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 13: Latin America Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 14: Latin America Central Lab Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 15: Latin America Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 16: Middle East & Africa Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 17: Middle East & Africa Central Lab Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 18: Middle East & Africa Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
List of Figures
Figure 01: Global Central Lab Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Central Lab Market Value Share, by Product, 2020
Figure 03: Global Central Lab Market Value Share, by End-user, 2020
Figure 04: Global Central Lab Market Value Share, by Region, 2020
Figure 05: Global Central Lab Market Value Share Analysis, by Product, 2020 and 2031
Figure 06: Global Central Lab Market Attractiveness Analysis, by Product, 2021–2031
Figure 07: Global Central Lab Market Revenue (US$ Mn), by Genetic Services, 2017–2031
Figure 08: Global Central Lab Market Revenue (US$ Mn), by Biomarker Services, 2017–2031
Figure 09: Global Central Lab Market Revenue (US$ Mn), by Microbiology Services, 2017–2031
Figure 10: Global Central Lab Market Revenue (US$ Mn), by Anatomic Pathology/Histology, 2017–2031
Figure 11: Global Central Lab Market Revenue (US$ Mn), by Specimen Management & Storage, 2017–2031
Figure 12: Global Central Lab Market Revenue (US$ Mn), by Special Chemistry Services, 2017–2031
Figure 13: Global Central Lab Market Revenue (US$ Mn), by Clinical Research & Trial Services, 2017–2031
Figure 14: Global Central Lab Market Revenue (US$ Mn), by Others, 2017–2031
Figure 15: Global Central Lab Market Value Share Analysis, by End-user, 2020 and 2031
Figure 16: Global Central Lab Market Attractiveness Analysis, by End-user, 2021–2031
Figure 17: Global Central Lab Market Revenue (US$ Mn), by Pharmaceutical Companies, 2017–2031
Figure 18: Global Central Lab Market Revenue (US$ Mn), by Biotechnology Companies, 2017–2031
Figure 19: Global Central Lab Market Revenue (US$ Mn), by Academic and Research Institutes, 2017–2031
Figure 20: Global Central Lab Market Value Share Analysis, by Region, 2020 and 2031
Figure 21: Global Central Lab Market Attractiveness Analysis, by Region, 2021–2031
Figure 22: North America Central Lab Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 23: North America Central Lab Market Value Share Analysis, by Country, 2020 and 2031
Figure 24: North America Central Lab Market Attractiveness Analysis, by Country, 2021–2031
Figure 25: North America Central Lab Market Value Share Analysis, by Product, 2020 and 2031
Figure 26: North America Central Lab Market Attractiveness Analysis, by Product, 2021–2031
Figure 27: North America Central Lab Market Value Share Analysis, by End-user, 2020 and 2031
Figure 28: North America Central Lab Market Attractiveness Analysis, by End-user, 2021–2031
Figure 29: Europe Central Lab Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 30: Europe Central Lab Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 31: Europe Central Lab Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 32: Europe Central Lab Market Value Share Analysis, by Product, 2020 and 2031
Figure 33: Europe Central Lab Market Attractiveness Analysis, by Product, 2021–2031
Figure 34: Europe Central Lab Market Value Share Analysis, by End-user, 2020 and 2031
Figure 35: Europe Central Lab Market Attractiveness Analysis, by End-user, 2021–2031
Figure 36: Asia Pacific Central Lab Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 37: Asia Pacific Central Lab Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 38: Asia Pacific Central Lab Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 39: Asia Pacific Central Lab Market Value Share Analysis, by Product, 2020 and 2031
Figure 40: Asia Pacific Central Lab Market Attractiveness Analysis, by Product, 2021–2031
Figure 41: Asia Pacific Central Lab Market Value Share Analysis, by End-user, 2020 and 2031
Figure 42: Asia Pacific Central Lab Market Attractiveness Analysis, by End-user, 2021–2031
Figure 43: Latin America Central Lab Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 44: Latin America Central Lab Market Value Share Analysis, by Country, 2020 and 2031
Figure 45: Latin America Central Lab Market Attractiveness Analysis, by Country, 2021–2031
Figure 46: Latin America Central Lab Market Value Share Analysis, by Product, 2020 and 2031
Figure 47: Latin America Central Lab Market Attractiveness Analysis, by Product, 2021–2031
Figure 48: Latin America Central Lab Market Value Share Analysis, by End-user, 2020 and 2031
Figure 49: Latin America Central Lab Market Attractiveness Analysis, by End-user, 2021–2031
Figure 50: Middle East & Africa Central Lab Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 51: Middle East & Africa Central Lab Market Value Share Analysis, by Country, 2020 and 2031
Figure 52: Middle East & Africa Central Lab Market Attractiveness Analysis, by Country, 2021–2031
Figure 53: Middle East & Africa Central Lab Market Value Share Analysis, by Product, 2020 and 2031
Figure 54: Middle East & Africa Central Lab Market Attractiveness Analysis, by Product, 2021–2031
Figure 55: Middle East & Africa Central Lab Market Value Share Analysis, by End-user, 2020 and 2031
Figure 56: Middle East & Africa Central Lab Market Attractiveness Analysis, by End-user, 2021–2031
Figure 57: Global Central Lab Market Share, by Company, 2020
Complete the form below and we'll get back to you shortly.
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
